Our findings support further assessment of the MMP-14 targeted peptide probes during image-guided resection of GBM, such as directly comparing the extent of NIRF-guided relative to 5-ALA-guided resection of preclinical GBM models as reported in other studies 63, 65. The gene discussed is MMP14; the disease is glioblastoma.